further elucidates -- Samberg appears to be at the nexus of an insider trading scandal with Pequot Capital and Microsoft (choice quote:'The day after Microsoft’s earnings announcement, Samberg emailed Zilkha: “I shouldn’t say this, but you probably have paid for yourself already.”')
Somehow, the Pequot investigation rose to the level of attention of SEC's Chairman Cox as well as Senator Charles Grassley ... Inveterate followers know that the testimony of Gary Aguirre is damning:
As commented upon elsewhere, AAPL is trading at 16X cash flow net of cash. From Apple's quarterly press releases, here's a table of cash + short term investments (in billions):
Cognoscenti know that Apple runs this cash through subsidiary Braeburn in Nevada, free from state income tax. If interest rates rise back up to the level of last year, a substantial portion of quarterly earnings will be interest income.
Genentech: Britain's National Health Won't Pay for Avastin [View article]
Writer 'nova' posits that Avastin has no survival advantage over FOLFOX chemotherapy, yet statistically-signific... studies such as ECOG 3200 show this is precisely the case, which is how Avastin received approval for this indication:
Even if we concede that the OS advantage is only 2-3 months (but longer for many, since this is a statistical median), that Britain's medical economists want to override their doctors' recommendations with hard-nosed evaluations of the worth of life extension would never fly across the pond.
It's not hard to imagine thousands of lawsuits against a doctors or insurance companies here in the States with the following preamble "Ladies and gentleman of the jury, do you mean to tell me that you cut my client's life eight weeks short because your cost-benefit analysis showed he was not worth the extra $10K cost of the drug combination over those weeks?". False economy!
Apple's iPhone: Home Court Advantage [View article]
The 10M number is about to be overtaken with "last year's model". This swarm of deals assumes new kit. Why is it hard for some to imagine that Apple can sell tens of millions when this has already occurred not just for Apple's own iPod, but for another cellphone, the Motorola RAZR, which shipped >50M for innovations in casing, not even in software. Look at the hockey-stick adoption curves at:
to see what portends for the iPhone. Of course, exponential growth tapers off, but for Apple it is just starting. From the perspective of a software developer, SDKs for the "competitor" cellphones mentioned by 'infestation' are quite primitive. Now Apple is ready to sell apps while Android is just getting off the ground. Apple's differentiators include software rollout for what is basically a miniature computer, in addition to the sleek hardware fit & finish coupled with a marketing juggernaut.
About that $50 per Java copy, Sun does get $50 per year per employee for carte blanche use of supported Java. Also every Blu-Ray player ships with Java, accruing per copy royalties to Sun. We aren't even counting the cellphones here.
Apple's Market Value to Surpass IBM, Intel [View article]
You forgot to mention the venerable Hewlett-Packard [HPQ] (now sitting just a shade above at a market cap of ~118B), which has very special meaning to Apple.
The irony stems from the fact that ye olde HP sat back and watched while Mssrs. Jobs & Wozniak pursued their destiny in the face of HP passing on the original Apple PC.
This would be big enough news to be passed on to Apple employees in email (as was the Apple-internal announcement about Dell) and perhaps coverage in the mainstream media.
Sort by:
Latest comments | Highest ratedIs Cisco Going to Compete with Apple in the Living Room? [View article]
On Mar 22 02:41 PM techseer wrote:
> Apple's not in the same league as Cisco in terms of revenue
From Yahoo Finance estimates:
CSCO current year (35.7B) next year (34.6B)
AAPL current year (35.1B) next year (40.1B)
What Happened to Dell? [View article]
blogs.zdnet.com/Apple/...
What to Buy and Why: Barron's 2009 Roundtable, Part I [View article]
> Where is Art Samberg this year?
For possible reasons why he isn't a Roundtable contributor, see:
www.signonsandiego.com...
about an influence-peddling scandal motivated by allegations
of insider trading involving Pequot Capital's Samberg.
www.deepcapture.com/94.../
further elucidates -- Samberg appears to be at the nexus
of an insider trading scandal with Pequot Capital and Microsoft
(choice quote:'The day after Microsoft’s earnings announcement, Samberg emailed Zilkha: “I shouldn’t say this, but you probably have paid for yourself already.”')
Somehow, the Pequot investigation rose to the level of attention of SEC's Chairman Cox as well as Senator Charles Grassley ... Inveterate followers know that the testimony of Gary Aguirre is damning:
www.whistleblower.org/...
This seems to be enough for persona-non-grata status.
Apple: Unlocking iPhone Profits [View article]
net of cash. From Apple's quarterly press releases, here's
a table of cash + short term investments (in billions):
Q1 07 11.8
Q2 07 12.6
Q3 07 13.7
Q4 07 15.4
Q1 08 18.4
Q2 08 19.5
Q3 08 20.7
Cognoscenti know that Apple runs this cash through subsidiary
Braeburn in Nevada, free from state income tax. If interest
rates rise back up to the level of last year, a substantial portion
of quarterly earnings will be interest income.
The Hidden Financial Impact of Apple's iPhone [View article]
MSRP by the way that purchasers are paying sales tax:
discussions.apple.com/...
Genentech: Britain's National Health Won't Pay for Avastin [View article]
chemotherapy, yet statistically-signific... studies such as ECOG 3200
show this is precisely the case, which is how Avastin received approval for this indication:
professional.cancercon...
Even if we concede that the OS advantage is only 2-3 months (but
longer for many, since this is a statistical median), that Britain's
medical economists want to override their doctors' recommendations
with hard-nosed evaluations of the worth of life extension would
never fly across the pond.
It's not hard to imagine thousands of lawsuits against a doctors or insurance companies here in the States with the following preamble "Ladies and gentleman of the jury, do you mean to tell me that
you cut my client's life eight weeks short because your
cost-benefit analysis showed he was not worth the extra $10K
cost of the drug combination over those weeks?". False economy!
Apple's iPhone: Home Court Advantage [View article]
This swarm of deals assumes new kit. Why is it hard for some
to imagine that Apple can sell tens of millions when this has already
occurred not just for Apple's own iPod, but for another cellphone,
the Motorola RAZR, which shipped >50M for innovations in
casing, not even in software. Look at the hockey-stick adoption
curves at:
money.cnn.com/2006/05/...
to see what portends for the iPhone. Of course, exponential growth
tapers off, but for Apple it is just starting. From the perspective of
a software developer, SDKs for the "competitor" cellphones mentioned
by 'infestation' are quite primitive. Now Apple is ready to sell apps while Android is just getting off the ground. Apple's differentiators
include software rollout for what is basically a miniature computer,
in addition to the sleek hardware fit & finish coupled with
a marketing juggernaut.
Buying MySQL Could Save Sun [View article]
for carte blanche use of supported Java. Also every Blu-Ray player
ships with Java, accruing per copy royalties to Sun. We aren't even counting the cellphones here.
Apple's Market Value to Surpass IBM, Intel [View article]
at a market cap of ~118B), which has very special meaning to Apple.
The irony stems from the fact that ye olde HP sat back and watched while Mssrs. Jobs & Wozniak
pursued their destiny in the face of HP passing on the original Apple PC.
This would be big enough news to be passed on to Apple employees in email (as was the
Apple-internal announcement about Dell) and perhaps coverage in the mainstream media.